Lataa...
Ligand‐centered assessment of SARS‐CoV‐2 drug target models in the Protein Data Bank
A bright spot in the SARS‐CoV‐2 (CoV‐2) coronavirus pandemic has been the immediate mobilization of the biomedical community, working to develop treatments and vaccines for COVID‐19. Rational drug design against emerging threats depends on well‐established methodology, mainly utilizing X‐ray crystal...
Tallennettuna:
| Julkaisussa: | FEBS J |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276724/ https://ncbi.nlm.nih.gov/pubmed/32418327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15366 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|